4//SEC Filing
Deck Kelly 4
Accession 0002007919-25-000037
CIK 0002007919other
Filed
Apr 1, 8:00 PM ET
Accepted
Apr 2, 4:39 PM ET
Size
5.7 KB
Accession
0002007919-25-000037
Insider Transaction Report
Form 4
Deck Kelly
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2025-04-01+15,000→ 15,000 totalExercise: $14.05Exp: 2035-04-01→ Common Stock (15,000 underlying)
Footnotes (1)
- [F1]Twenty-five percent (25%) of the total shares subject to this stock option will become exercisable on April 1, 2026, with the balance to vest and become exercisable in equal successive monthly installments for thirty-six (36) months thereafter, subject to the Reporting Person's continuous service to the Issuer through each vesting date.
Documents
Issuer
Inhibrx Biosciences, Inc.
CIK 0002007919
Entity typeother
Related Parties
1- filerCIK 0001819427
Filing Metadata
- Form type
- 4
- Filed
- Apr 1, 8:00 PM ET
- Accepted
- Apr 2, 4:39 PM ET
- Size
- 5.7 KB